Inflammatory bowel disease (IBD) represents a group of intestinal disorders that cause chronic inflammation of the digestive tract [1]. The digestive tract, which comprises the mouth, oesophagus, stomach, small intestine, and large intestine, is responsible for breaking down food, extracting the nutrients, and removing any unusable material and waste products from the body [2].
IBD are of two types, ulcerative colitis and Crohn's disease. Ulcerative colitis causes long-lasting inflammation and ulcers in the inner lining of your large intestine and rectum, and Crohn's disease is characterised by inflammation of the lining of your digestive tract [3][4].
COVID-19 And Breast Cancer
Health experts have pointed out that, even though the coronavirus disease affects the respiratory system, some cases of COVID-19 involve symptoms in the digestive system - which can worsen the symptoms of IBD [5].
Are People With IBD At An Increased Risk Of COVID-19?
While discussing the link between IBD and COVID-19, health experts pointed out that some treatments for IBD may suppress the immune system, thereby increasing the person's risk of contracting the coronavirus infection [6].
COVID-19 And Migraine
Use of long-term steroids, anti-tumour necrosis factor biologics, immunomodulators and other biologic drugs suppress the immune system to help control IBD symptoms such as diarrhoea, bleeding ulcers, stomach pain and weight loss [7]. In the same way, these medicines help manage the symptoms of the condition - they can put people at greater risk of COVID-19 or its complications [8].
A person with IBD who also fits into the category of people at an increased risk of COVID-19, such as pregnant women, people over the age of 65 and people with active-stage IBD who are at risk of malnutrition may be at greater risk of infection.
However, in a study published in the Journal of Crohn's and Colitis states that people with IBD do not have an increased risk of COVID-19 [9].
No comments:
Post a Comment